x

Global Diabetic Macular Edema Treatment Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application

Published Date: 2019-04-13   |   Pages: 96   |   Tables: 106   | Report Id: 1119388   | Hits: 72 |   Medical Care

category cover


Summary


Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema.

Increasing prevalence of diabetes in the prime factor driving growth of global diabetic macular edema therapeutics market. The prevalence of diabetic macular edema is higher in type 2 diabetes patients than in type 1 diabetes patients. As per study conducted by University Hospital Sant Joan de Reus Spain, the incidence of diabetic macular edema is in the range of 0.9%-2.3%, annually, across the globe. Besides this, substantial R&D investment by pharmaceutical companies and advancement in ophthalmic surgrey techniques are some other factors fueling the growth of global diabetic macular edema treatment market.

In 2018, the global Diabetic Macular Edema Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% between 2019 and 2025.


This report studies the Diabetic Macular Edema Treatment market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.


This report focuses on the global top players, covered

Genentech

Novartis

GlaxoSmithKline

Eyetech Pharmaceuticals

Alimera Sciences

...


Market segment by Regions/Countries, this report covers

North America

Europe

China

Rest of Asia Pacific

Central & South America

Middle East & Africa


Market segment by Type, the product can be split into

Laser Photocoagulation Therapy

Pharmacological Therapy

Bevacizumab

Ranibizumab

Triamcinolone


Market segment by Application, the market can be split into

Hospitals

Ophthalmic Clinics

Research Institutes

Contract Research Organizations


The study objectives of this report are:

To study and forecast the market size of Diabetic Macular Edema Treatment in global market.

To analyze the global key players, SWOT analysis, value and global market share for top players.

To define, describe and forecast the market by type, end use and region.

To analyze and compare the market status and forecast among global major regions.

To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


In this study, the years considered to estimate the market size of Diabetic Macular Edema Treatment are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Key Stakeholders

Raw material suppliers

Distributors/traders/wholesalers/suppliers

Regulatory bodies, including government agencies and NGO

Commercial research & development (R&D) institutions

Importers and exporters

Government organizations, research organizations, and consulting firms

Trade associations and industry bodies

End-use industries


Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Further breakdown of Diabetic Macular Edema Treatment market on basis of the key contributing countries.

Detailed analysis and profiling of additional market players.

Licenses Type

Only one user can access the report
Multiple users can access the report

Why QYR

 Fastest report delivery service
 More than 10 years of vast experience
 Operational for 24 * 7 & 365 days
 In-depth and comprehensive analysis
 Excellent after sales support
 Owns large database

Need Help ?

Global Diabetic Macular Edema Treatment market

QYR Clients

  • csl
  • croozer
  • crital alert
  • cristal
  • corveneng
  • coperion
  • contijpi medical
  • compass minerals
More Clients...